Skip to main content
 
  • Anne Drapkin Lyerly

Editorial

In this issue of JAMA Psychiatry, Heil et al1 report a randomized clinical trial to evaluate the efficacy and cost benefits of interventions to increase prescription contraceptive use among women with opioid use disorder (OUD) at risk for unintended pregnancy. The study found that verified contraception use was highest and unintended pregnancy rates were lowest among women randomized to receive 2 interventions: onsite contraceptive services plus a financial incentive to return for follow-up visits